switching glp 1 Patients without diabetes who switched between glucagon-like peptide-1 receptor agonist (GLP-1RA) medications for overweight or obesity were more likely to remain engaged with treatment than those who stayed on the same medication How to take GLP-1 drops:
Description
98.1% of patients reported at least 20 pounds of weight loss

As an obesity specialist and hypertension specialist, I often assess the broader context of sleep, autonomic tone, thyroid function, and electrolyte status

Judi Chervenak, M.D

This story was produced by GoodRx and reviewed and distributed by Stacker.
